Dry Powder Inhaler Device Industry Research Report 2024
Summary
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
According to APO Research, the global Dry Powder Inhaler Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Dry Powder Inhaler Device include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dry Powder Inhaler Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Powder Inhaler Device.
The report will help the Dry Powder Inhaler Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Dry Powder Inhaler Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Powder Inhaler Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Powder Inhaler Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Powder Inhaler Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Powder Inhaler Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dry Powder Inhaler Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dry Powder Inhaler Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
According to APO Research, the global Dry Powder Inhaler Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Dry Powder Inhaler Device is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Dry Powder Inhaler Device include GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Dry Powder Inhaler Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dry Powder Inhaler Device.
The report will help the Dry Powder Inhaler Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Dry Powder Inhaler Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dry Powder Inhaler Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GlaxoSmithKline
- AstraZeneca
- Boehringer Ingelheim
- Chiesi
- Cipla
- 3M
- Hovione
- Mannkind
- Mylan
- Novartis
- Schering/Merck
- Teva
- Vectura
- Single Dose
- Multi Dose
- Asthma
- COPD
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dry Powder Inhaler Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dry Powder Inhaler Device and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dry Powder Inhaler Device.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dry Powder Inhaler Device manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dry Powder Inhaler Device by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dry Powder Inhaler Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Dry Powder Inhaler Device Market Size (2019-2030) & (US$ Million)
2.2.2 Global Dry Powder Inhaler Device Sales (2019-2030)
2.2.3 Global Dry Powder Inhaler Device Market Average Price (2019-2030)
2.3 Dry Powder Inhaler Device by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Single Dose
2.3.3 Multi Dose
2.4 Dry Powder Inhaler Device by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Asthma
2.4.3 COPD
2.4.4 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Dry Powder Inhaler Device Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Dry Powder Inhaler Device Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Dry Powder Inhaler Device Revenue of Manufacturers (2019-2024)
3.4 Global Dry Powder Inhaler Device Average Price by Manufacturers (2019-2024)
3.5 Global Dry Powder Inhaler Device Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Dry Powder Inhaler Device, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Dry Powder Inhaler Device, Product Type & Application
3.8 Global Manufacturers of Dry Powder Inhaler Device, Date of Enter into This Industry
3.9 Global Dry Powder Inhaler Device Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 GlaxoSmithKline
4.1.1 GlaxoSmithKline Company Information
4.1.2 GlaxoSmithKline Business Overview
4.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
4.1.5 GlaxoSmithKline Recent Developments
4.2 AstraZeneca
4.2.1 AstraZeneca Company Information
4.2.2 AstraZeneca Business Overview
4.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio
4.2.5 AstraZeneca Recent Developments
4.3 Boehringer Ingelheim
4.3.1 Boehringer Ingelheim Company Information
4.3.2 Boehringer Ingelheim Business Overview
4.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
4.3.5 Boehringer Ingelheim Recent Developments
4.4 Chiesi
4.4.1 Chiesi Company Information
4.4.2 Chiesi Business Overview
4.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio
4.4.5 Chiesi Recent Developments
4.5 Cipla
4.5.1 Cipla Company Information
4.5.2 Cipla Business Overview
4.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Cipla Dry Powder Inhaler Device Product Portfolio
4.5.5 Cipla Recent Developments
4.6 3M
4.6.1 3M Company Information
4.6.2 3M Business Overview
4.6.3 3M Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.6.4 3M Dry Powder Inhaler Device Product Portfolio
4.6.5 3M Recent Developments
4.7 Hovione
4.7.1 Hovione Company Information
4.7.2 Hovione Business Overview
4.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Hovione Dry Powder Inhaler Device Product Portfolio
4.7.5 Hovione Recent Developments
4.8 Mannkind
4.8.1 Mannkind Company Information
4.8.2 Mannkind Business Overview
4.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio
4.8.5 Mannkind Recent Developments
4.9 Mylan
4.9.1 Mylan Company Information
4.9.2 Mylan Business Overview
4.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Mylan Dry Powder Inhaler Device Product Portfolio
4.9.5 Mylan Recent Developments
4.10 Novartis
4.10.1 Novartis Company Information
4.10.2 Novartis Business Overview
4.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Novartis Dry Powder Inhaler Device Product Portfolio
4.10.5 Novartis Recent Developments
4.11 Schering/Merck
4.11.1 Schering/Merck Company Information
4.11.2 Schering/Merck Business Overview
4.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio
4.11.5 Schering/Merck Recent Developments
4.12 Teva
4.12.1 Teva Company Information
4.12.2 Teva Business Overview
4.12.3 Teva Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Teva Dry Powder Inhaler Device Product Portfolio
4.12.5 Teva Recent Developments
4.13 Vectura
4.13.1 Vectura Company Information
4.13.2 Vectura Business Overview
4.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Vectura Dry Powder Inhaler Device Product Portfolio
4.13.5 Vectura Recent Developments
5 GLOBAL DRY POWDER INHALER DEVICE MARKET SCENARIO BY REGION
5.1 Global Dry Powder Inhaler Device Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Dry Powder Inhaler Device Sales by Region: 2019-2030
5.2.1 Global Dry Powder Inhaler Device Sales by Region: 2019-2024
5.2.2 Global Dry Powder Inhaler Device Sales by Region: 2025-2030
5.3 Global Dry Powder Inhaler Device Revenue by Region: 2019-2030
5.3.1 Global Dry Powder Inhaler Device Revenue by Region: 2019-2024
5.3.2 Global Dry Powder Inhaler Device Revenue by Region: 2025-2030
5.4 North America Dry Powder Inhaler Device Market Facts & Figures by Country
5.4.1 North America Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Dry Powder Inhaler Device Sales by Country (2019-2030)
5.4.3 North America Dry Powder Inhaler Device Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Dry Powder Inhaler Device Market Facts & Figures by Country
5.5.1 Europe Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Dry Powder Inhaler Device Sales by Country (2019-2030)
5.5.3 Europe Dry Powder Inhaler Device Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Dry Powder Inhaler Device Market Facts & Figures by Country
5.6.1 Asia Pacific Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Dry Powder Inhaler Device Sales by Country (2019-2030)
5.6.3 Asia Pacific Dry Powder Inhaler Device Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Dry Powder Inhaler Device Market Facts & Figures by Country
5.7.1 Latin America Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Dry Powder Inhaler Device Sales by Country (2019-2030)
5.7.3 Latin America Dry Powder Inhaler Device Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Dry Powder Inhaler Device Market Facts & Figures by Country
5.8.1 Middle East and Africa Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Dry Powder Inhaler Device Sales by Country (2019-2030)
5.8.3 Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Dry Powder Inhaler Device Sales by Type (2019-2030)
6.1.1 Global Dry Powder Inhaler Device Sales by Type (2019-2030) & (K Units)
6.1.2 Global Dry Powder Inhaler Device Sales Market Share by Type (2019-2030)
6.2 Global Dry Powder Inhaler Device Revenue by Type (2019-2030)
6.2.1 Global Dry Powder Inhaler Device Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Dry Powder Inhaler Device Revenue Market Share by Type (2019-2030)
6.3 Global Dry Powder Inhaler Device Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Dry Powder Inhaler Device Sales by Application (2019-2030)
7.1.1 Global Dry Powder Inhaler Device Sales by Application (2019-2030) & (K Units)
7.1.2 Global Dry Powder Inhaler Device Sales Market Share by Application (2019-2030)
7.2 Global Dry Powder Inhaler Device Revenue by Application (2019-2030)
7.2.1 Global Dry Powder Inhaler Device Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Dry Powder Inhaler Device Revenue Market Share by Application (2019-2030)
7.3 Global Dry Powder Inhaler Device Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Dry Powder Inhaler Device Value Chain Analysis
8.1.1 Dry Powder Inhaler Device Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Dry Powder Inhaler Device Production Mode & Process
8.2 Dry Powder Inhaler Device Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Dry Powder Inhaler Device Distributors
8.2.3 Dry Powder Inhaler Device Customers
9 GLOBAL DRY POWDER INHALER DEVICE ANALYZING MARKET DYNAMICS
9.1 Dry Powder Inhaler Device Industry Trends
9.2 Dry Powder Inhaler Device Industry Drivers
9.3 Dry Powder Inhaler Device Industry Opportunities and Challenges
9.4 Dry Powder Inhaler Device Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Dry Powder Inhaler Device Market Size (2019-2030) & (US$ Million)
2.2.2 Global Dry Powder Inhaler Device Sales (2019-2030)
2.2.3 Global Dry Powder Inhaler Device Market Average Price (2019-2030)
2.3 Dry Powder Inhaler Device by Type
2.3.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
2.3.2 Single Dose
2.3.3 Multi Dose
2.4 Dry Powder Inhaler Device by Application
2.4.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
2.4.2 Asthma
2.4.3 COPD
2.4.4 Others
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global Dry Powder Inhaler Device Market Competitive Situation by Manufacturers (2019 Versus 2023)
3.2 Global Dry Powder Inhaler Device Sales (K Units) of Manufacturers (2019-2024)
3.3 Global Dry Powder Inhaler Device Revenue of Manufacturers (2019-2024)
3.4 Global Dry Powder Inhaler Device Average Price by Manufacturers (2019-2024)
3.5 Global Dry Powder Inhaler Device Industry Ranking, 2022 VS 2023 VS 2024
3.6 Global Manufacturers of Dry Powder Inhaler Device, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Dry Powder Inhaler Device, Product Type & Application
3.8 Global Manufacturers of Dry Powder Inhaler Device, Date of Enter into This Industry
3.9 Global Dry Powder Inhaler Device Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 GlaxoSmithKline
4.1.1 GlaxoSmithKline Company Information
4.1.2 GlaxoSmithKline Business Overview
4.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.1.4 GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
4.1.5 GlaxoSmithKline Recent Developments
4.2 AstraZeneca
4.2.1 AstraZeneca Company Information
4.2.2 AstraZeneca Business Overview
4.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.2.4 AstraZeneca Dry Powder Inhaler Device Product Portfolio
4.2.5 AstraZeneca Recent Developments
4.3 Boehringer Ingelheim
4.3.1 Boehringer Ingelheim Company Information
4.3.2 Boehringer Ingelheim Business Overview
4.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.3.4 Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
4.3.5 Boehringer Ingelheim Recent Developments
4.4 Chiesi
4.4.1 Chiesi Company Information
4.4.2 Chiesi Business Overview
4.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.4.4 Chiesi Dry Powder Inhaler Device Product Portfolio
4.4.5 Chiesi Recent Developments
4.5 Cipla
4.5.1 Cipla Company Information
4.5.2 Cipla Business Overview
4.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.5.4 Cipla Dry Powder Inhaler Device Product Portfolio
4.5.5 Cipla Recent Developments
4.6 3M
4.6.1 3M Company Information
4.6.2 3M Business Overview
4.6.3 3M Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.6.4 3M Dry Powder Inhaler Device Product Portfolio
4.6.5 3M Recent Developments
4.7 Hovione
4.7.1 Hovione Company Information
4.7.2 Hovione Business Overview
4.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.7.4 Hovione Dry Powder Inhaler Device Product Portfolio
4.7.5 Hovione Recent Developments
4.8 Mannkind
4.8.1 Mannkind Company Information
4.8.2 Mannkind Business Overview
4.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.8.4 Mannkind Dry Powder Inhaler Device Product Portfolio
4.8.5 Mannkind Recent Developments
4.9 Mylan
4.9.1 Mylan Company Information
4.9.2 Mylan Business Overview
4.9.3 Mylan Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.9.4 Mylan Dry Powder Inhaler Device Product Portfolio
4.9.5 Mylan Recent Developments
4.10 Novartis
4.10.1 Novartis Company Information
4.10.2 Novartis Business Overview
4.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.10.4 Novartis Dry Powder Inhaler Device Product Portfolio
4.10.5 Novartis Recent Developments
4.11 Schering/Merck
4.11.1 Schering/Merck Company Information
4.11.2 Schering/Merck Business Overview
4.11.3 Schering/Merck Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.11.4 Schering/Merck Dry Powder Inhaler Device Product Portfolio
4.11.5 Schering/Merck Recent Developments
4.12 Teva
4.12.1 Teva Company Information
4.12.2 Teva Business Overview
4.12.3 Teva Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.12.4 Teva Dry Powder Inhaler Device Product Portfolio
4.12.5 Teva Recent Developments
4.13 Vectura
4.13.1 Vectura Company Information
4.13.2 Vectura Business Overview
4.13.3 Vectura Dry Powder Inhaler Device Sales, Revenue and Gross Margin (2019-2024)
4.13.4 Vectura Dry Powder Inhaler Device Product Portfolio
4.13.5 Vectura Recent Developments
5 GLOBAL DRY POWDER INHALER DEVICE MARKET SCENARIO BY REGION
5.1 Global Dry Powder Inhaler Device Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Dry Powder Inhaler Device Sales by Region: 2019-2030
5.2.1 Global Dry Powder Inhaler Device Sales by Region: 2019-2024
5.2.2 Global Dry Powder Inhaler Device Sales by Region: 2025-2030
5.3 Global Dry Powder Inhaler Device Revenue by Region: 2019-2030
5.3.1 Global Dry Powder Inhaler Device Revenue by Region: 2019-2024
5.3.2 Global Dry Powder Inhaler Device Revenue by Region: 2025-2030
5.4 North America Dry Powder Inhaler Device Market Facts & Figures by Country
5.4.1 North America Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
5.4.2 North America Dry Powder Inhaler Device Sales by Country (2019-2030)
5.4.3 North America Dry Powder Inhaler Device Revenue by Country (2019-2030)
5.4.4 U.S.
5.4.5 Canada
5.5 Europe Dry Powder Inhaler Device Market Facts & Figures by Country
5.5.1 Europe Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
5.5.2 Europe Dry Powder Inhaler Device Sales by Country (2019-2030)
5.5.3 Europe Dry Powder Inhaler Device Revenue by Country (2019-2030)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Dry Powder Inhaler Device Market Facts & Figures by Country
5.6.1 Asia Pacific Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
5.6.2 Asia Pacific Dry Powder Inhaler Device Sales by Country (2019-2030)
5.6.3 Asia Pacific Dry Powder Inhaler Device Revenue by Country (2019-2030)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Dry Powder Inhaler Device Market Facts & Figures by Country
5.7.1 Latin America Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
5.7.2 Latin America Dry Powder Inhaler Device Sales by Country (2019-2030)
5.7.3 Latin America Dry Powder Inhaler Device Revenue by Country (2019-2030)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Dry Powder Inhaler Device Market Facts & Figures by Country
5.8.1 Middle East and Africa Dry Powder Inhaler Device Market Size by Country: 2019 VS 2023 VS 2030
5.8.2 Middle East and Africa Dry Powder Inhaler Device Sales by Country (2019-2030)
5.8.3 Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2019-2030)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 SEGMENT BY TYPE
6.1 Global Dry Powder Inhaler Device Sales by Type (2019-2030)
6.1.1 Global Dry Powder Inhaler Device Sales by Type (2019-2030) & (K Units)
6.1.2 Global Dry Powder Inhaler Device Sales Market Share by Type (2019-2030)
6.2 Global Dry Powder Inhaler Device Revenue by Type (2019-2030)
6.2.1 Global Dry Powder Inhaler Device Sales by Type (2019-2030) & (US$ Million)
6.2.2 Global Dry Powder Inhaler Device Revenue Market Share by Type (2019-2030)
6.3 Global Dry Powder Inhaler Device Price by Type (2019-2030)
7 SEGMENT BY APPLICATION
7.1 Global Dry Powder Inhaler Device Sales by Application (2019-2030)
7.1.1 Global Dry Powder Inhaler Device Sales by Application (2019-2030) & (K Units)
7.1.2 Global Dry Powder Inhaler Device Sales Market Share by Application (2019-2030)
7.2 Global Dry Powder Inhaler Device Revenue by Application (2019-2030)
7.2.1 Global Dry Powder Inhaler Device Sales by Application (2019-2030) & (US$ Million)
7.2.2 Global Dry Powder Inhaler Device Revenue Market Share by Application (2019-2030)
7.3 Global Dry Powder Inhaler Device Price by Application (2019-2030)
8 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
8.1 Dry Powder Inhaler Device Value Chain Analysis
8.1.1 Dry Powder Inhaler Device Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Dry Powder Inhaler Device Production Mode & Process
8.2 Dry Powder Inhaler Device Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Dry Powder Inhaler Device Distributors
8.2.3 Dry Powder Inhaler Device Customers
9 GLOBAL DRY POWDER INHALER DEVICE ANALYZING MARKET DYNAMICS
9.1 Dry Powder Inhaler Device Industry Trends
9.2 Dry Powder Inhaler Device Industry Drivers
9.3 Dry Powder Inhaler Device Industry Opportunities and Challenges
9.4 Dry Powder Inhaler Device Industry Restraints
10 REPORT CONCLUSION
11 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Dry Powder Inhaler Device Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Dry Powder Inhaler Device Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Dry Powder Inhaler Device Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Dry Powder Inhaler Device Revenue of Manufacturers (2018-2023)
Table 9. Global Dry Powder Inhaler Device Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Dry Powder Inhaler Device Average Price (USD/Unit) of Manufacturers (2018-2023)
Table 11. Global Dry Powder Inhaler Device Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Dry Powder Inhaler Device, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dry Powder Inhaler Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. GlaxoSmithKline Company Information
Table 17. GlaxoSmithKline Business Overview
Table 18. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 19. GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
Table 20. GlaxoSmithKline Recent Developments
Table 21. AstraZeneca Company Information
Table 22. AstraZeneca Business Overview
Table 23. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 24. AstraZeneca Dry Powder Inhaler Device Product Portfolio
Table 25. AstraZeneca Recent Developments
Table 26. Boehringer Ingelheim Company Information
Table 27. Boehringer Ingelheim Business Overview
Table 28. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 29. Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
Table 30. Boehringer Ingelheim Recent Developments
Table 31. Chiesi Company Information
Table 32. Chiesi Business Overview
Table 33. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 34. Chiesi Dry Powder Inhaler Device Product Portfolio
Table 35. Chiesi Recent Developments
Table 36. Cipla Company Information
Table 37. Cipla Business Overview
Table 38. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 39. Cipla Dry Powder Inhaler Device Product Portfolio
Table 40. Cipla Recent Developments
Table 41. 3M Company Information
Table 42. 3M Business Overview
Table 43. 3M Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 44. 3M Dry Powder Inhaler Device Product Portfolio
Table 45. 3M Recent Developments
Table 46. Hovione Company Information
Table 47. Hovione Business Overview
Table 48. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 49. Hovione Dry Powder Inhaler Device Product Portfolio
Table 50. Hovione Recent Developments
Table 51. Mannkind Company Information
Table 52. Mannkind Business Overview
Table 53. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 54. Mannkind Dry Powder Inhaler Device Product Portfolio
Table 55. Mannkind Recent Developments
Table 56. Mylan Company Information
Table 57. Mylan Business Overview
Table 58. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. Mylan Dry Powder Inhaler Device Product Portfolio
Table 60. Mylan Recent Developments
Table 61. Novartis Company Information
Table 62. Novartis Business Overview
Table 63. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 64. Novartis Dry Powder Inhaler Device Product Portfolio
Table 65. Novartis Recent Developments
Table 66. Schering/Merck Company Information
Table 67. Schering/Merck Business Overview
Table 68. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 69. Schering/Merck Dry Powder Inhaler Device Product Portfolio
Table 70. Schering/Merck Recent Developments
Table 71. Teva Company Information
Table 72. Teva Business Overview
Table 73. Teva Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 74. Teva Dry Powder Inhaler Device Product Portfolio
Table 75. Teva Recent Developments
Table 76. Vectura Company Information
Table 77. Vectura Business Overview
Table 78. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 79. Vectura Dry Powder Inhaler Device Product Portfolio
Table 80. Vectura Recent Developments
Table 81. Global Dry Powder Inhaler Device Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 82. Global Dry Powder Inhaler Device Sales by Region (2018-2023) & (K Units)
Table 83. Global Dry Powder Inhaler Device Sales Market Share by Region (2018-2023)
Table 84. Global Dry Powder Inhaler Device Sales by Region (2024-2029) & (K Units)
Table 85. Global Dry Powder Inhaler Device Sales Market Share by Region (2024-2029)
Table 86. Global Dry Powder Inhaler Device Revenue by Region (2018-2023) & (US$ Million)
Table 87. Global Dry Powder Inhaler Device Revenue Market Share by Region (2018-2023)
Table 88. Global Dry Powder Inhaler Device Revenue by Region (2024-2029) & (US$ Million)
Table 89. Global Dry Powder Inhaler Device Revenue Market Share by Region (2024-2029)
Table 90. North America Dry Powder Inhaler Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. North America Dry Powder Inhaler Device Sales by Country (2018-2023) & (K Units)
Table 92. North America Dry Powder Inhaler Device Sales by Country (2024-2029) & (K Units)
Table 93. North America Dry Powder Inhaler Device Revenue by Country (2018-2023) & (US$ Million)
Table 94. North America Dry Powder Inhaler Device Revenue by Country (2024-2029) & (US$ Million)
Table 95. Europe Dry Powder Inhaler Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Europe Dry Powder Inhaler Device Sales by Country (2018-2023) & (K Units)
Table 97. Europe Dry Powder Inhaler Device Sales by Country (2024-2029) & (K Units)
Table 98. Europe Dry Powder Inhaler Device Revenue by Country (2018-2023) & (US$ Million)
Table 99. Europe Dry Powder Inhaler Device Revenue by Country (2024-2029) & (US$ Million)
Table 100. Asia Pacific Dry Powder Inhaler Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Asia Pacific Dry Powder Inhaler Device Sales by Country (2018-2023) & (K Units)
Table 102. Asia Pacific Dry Powder Inhaler Device Sales by Country (2024-2029) & (K Units)
Table 103. Asia Pacific Dry Powder Inhaler Device Revenue by Country (2018-2023) & (US$ Million)
Table 104. Asia Pacific Dry Powder Inhaler Device Revenue by Country (2024-2029) & (US$ Million)
Table 105. Latin America Dry Powder Inhaler Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Latin America Dry Powder Inhaler Device Sales by Country (2018-2023) & (K Units)
Table 107. Latin America Dry Powder Inhaler Device Sales by Country (2024-2029) & (K Units)
Table 108. Latin America Dry Powder Inhaler Device Revenue by Country (2018-2023) & (US$ Million)
Table 109. Latin America Dry Powder Inhaler Device Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East and Africa Dry Powder Inhaler Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Middle East and Africa Dry Powder Inhaler Device Sales by Country (2018-2023) & (K Units)
Table 112. Middle East and Africa Dry Powder Inhaler Device Sales by Country (2024-2029) & (K Units)
Table 113. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2024-2029) & (US$ Million)
Table 115. Global Dry Powder Inhaler Device Sales by Type (2018-2023) & (K Units)
Table 116. Global Dry Powder Inhaler Device Sales by Type (2024-2029) & (K Units)
Table 117. Global Dry Powder Inhaler Device Sales Market Share by Type (2018-2023)
Table 118. Global Dry Powder Inhaler Device Sales Market Share by Type (2024-2029)
Table 119. Global Dry Powder Inhaler Device Revenue by Type (2018-2023) & (US$ Million)
Table 120. Global Dry Powder Inhaler Device Revenue by Type (2024-2029) & (US$ Million)
Table 121. Global Dry Powder Inhaler Device Revenue Market Share by Type (2018-2023)
Table 122. Global Dry Powder Inhaler Device Revenue Market Share by Type (2024-2029)
Table 123. Global Dry Powder Inhaler Device Price by Type (2018-2023) & (USD/Unit)
Table 124. Global Dry Powder Inhaler Device Price by Type (2024-2029) & (USD/Unit)
Table 125. Global Dry Powder Inhaler Device Sales by Application (2018-2023) & (K Units)
Table 126. Global Dry Powder Inhaler Device Sales by Application (2024-2029) & (K Units)
Table 127. Global Dry Powder Inhaler Device Sales Market Share by Application (2018-2023)
Table 128. Global Dry Powder Inhaler Device Sales Market Share by Application (2024-2029)
Table 129. Global Dry Powder Inhaler Device Revenue by Application (2018-2023) & (US$ Million)
Table 130. Global Dry Powder Inhaler Device Revenue by Application (2024-2029) & (US$ Million)
Table 131. Global Dry Powder Inhaler Device Revenue Market Share by Application (2018-2023)
Table 132. Global Dry Powder Inhaler Device Revenue Market Share by Application (2024-2029)
Table 133. Global Dry Powder Inhaler Device Price by Application (2018-2023) & (USD/Unit)
Table 134. Global Dry Powder Inhaler Device Price by Application (2024-2029) & (USD/Unit)
Table 135. Key Raw Materials
Table 136. Raw Materials Key Suppliers
Table 137. Dry Powder Inhaler Device Distributors List
Table 138. Dry Powder Inhaler Device Customers List
Table 139. Dry Powder Inhaler Device Industry Trends
Table 140. Dry Powder Inhaler Device Industry Drivers
Table 141. Dry Powder Inhaler Device Industry Restraints
Table 142. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Dry Powder Inhaler Device Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Dry Powder Inhaler Device Sales (K Units) of Manufacturers (2018-2023)
Table 7. Global Dry Powder Inhaler Device Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Dry Powder Inhaler Device Revenue of Manufacturers (2018-2023)
Table 9. Global Dry Powder Inhaler Device Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Dry Powder Inhaler Device Average Price (USD/Unit) of Manufacturers (2018-2023)
Table 11. Global Dry Powder Inhaler Device Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Dry Powder Inhaler Device, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dry Powder Inhaler Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. GlaxoSmithKline Company Information
Table 17. GlaxoSmithKline Business Overview
Table 18. GlaxoSmithKline Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 19. GlaxoSmithKline Dry Powder Inhaler Device Product Portfolio
Table 20. GlaxoSmithKline Recent Developments
Table 21. AstraZeneca Company Information
Table 22. AstraZeneca Business Overview
Table 23. AstraZeneca Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 24. AstraZeneca Dry Powder Inhaler Device Product Portfolio
Table 25. AstraZeneca Recent Developments
Table 26. Boehringer Ingelheim Company Information
Table 27. Boehringer Ingelheim Business Overview
Table 28. Boehringer Ingelheim Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 29. Boehringer Ingelheim Dry Powder Inhaler Device Product Portfolio
Table 30. Boehringer Ingelheim Recent Developments
Table 31. Chiesi Company Information
Table 32. Chiesi Business Overview
Table 33. Chiesi Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 34. Chiesi Dry Powder Inhaler Device Product Portfolio
Table 35. Chiesi Recent Developments
Table 36. Cipla Company Information
Table 37. Cipla Business Overview
Table 38. Cipla Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 39. Cipla Dry Powder Inhaler Device Product Portfolio
Table 40. Cipla Recent Developments
Table 41. 3M Company Information
Table 42. 3M Business Overview
Table 43. 3M Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 44. 3M Dry Powder Inhaler Device Product Portfolio
Table 45. 3M Recent Developments
Table 46. Hovione Company Information
Table 47. Hovione Business Overview
Table 48. Hovione Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 49. Hovione Dry Powder Inhaler Device Product Portfolio
Table 50. Hovione Recent Developments
Table 51. Mannkind Company Information
Table 52. Mannkind Business Overview
Table 53. Mannkind Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 54. Mannkind Dry Powder Inhaler Device Product Portfolio
Table 55. Mannkind Recent Developments
Table 56. Mylan Company Information
Table 57. Mylan Business Overview
Table 58. Mylan Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. Mylan Dry Powder Inhaler Device Product Portfolio
Table 60. Mylan Recent Developments
Table 61. Novartis Company Information
Table 62. Novartis Business Overview
Table 63. Novartis Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 64. Novartis Dry Powder Inhaler Device Product Portfolio
Table 65. Novartis Recent Developments
Table 66. Schering/Merck Company Information
Table 67. Schering/Merck Business Overview
Table 68. Schering/Merck Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 69. Schering/Merck Dry Powder Inhaler Device Product Portfolio
Table 70. Schering/Merck Recent Developments
Table 71. Teva Company Information
Table 72. Teva Business Overview
Table 73. Teva Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 74. Teva Dry Powder Inhaler Device Product Portfolio
Table 75. Teva Recent Developments
Table 76. Vectura Company Information
Table 77. Vectura Business Overview
Table 78. Vectura Dry Powder Inhaler Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 79. Vectura Dry Powder Inhaler Device Product Portfolio
Table 80. Vectura Recent Developments
Table 81. Global Dry Powder Inhaler Device Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 82. Global Dry Powder Inhaler Device Sales by Region (2018-2023) & (K Units)
Table 83. Global Dry Powder Inhaler Device Sales Market Share by Region (2018-2023)
Table 84. Global Dry Powder Inhaler Device Sales by Region (2024-2029) & (K Units)
Table 85. Global Dry Powder Inhaler Device Sales Market Share by Region (2024-2029)
Table 86. Global Dry Powder Inhaler Device Revenue by Region (2018-2023) & (US$ Million)
Table 87. Global Dry Powder Inhaler Device Revenue Market Share by Region (2018-2023)
Table 88. Global Dry Powder Inhaler Device Revenue by Region (2024-2029) & (US$ Million)
Table 89. Global Dry Powder Inhaler Device Revenue Market Share by Region (2024-2029)
Table 90. North America Dry Powder Inhaler Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. North America Dry Powder Inhaler Device Sales by Country (2018-2023) & (K Units)
Table 92. North America Dry Powder Inhaler Device Sales by Country (2024-2029) & (K Units)
Table 93. North America Dry Powder Inhaler Device Revenue by Country (2018-2023) & (US$ Million)
Table 94. North America Dry Powder Inhaler Device Revenue by Country (2024-2029) & (US$ Million)
Table 95. Europe Dry Powder Inhaler Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 96. Europe Dry Powder Inhaler Device Sales by Country (2018-2023) & (K Units)
Table 97. Europe Dry Powder Inhaler Device Sales by Country (2024-2029) & (K Units)
Table 98. Europe Dry Powder Inhaler Device Revenue by Country (2018-2023) & (US$ Million)
Table 99. Europe Dry Powder Inhaler Device Revenue by Country (2024-2029) & (US$ Million)
Table 100. Asia Pacific Dry Powder Inhaler Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 101. Asia Pacific Dry Powder Inhaler Device Sales by Country (2018-2023) & (K Units)
Table 102. Asia Pacific Dry Powder Inhaler Device Sales by Country (2024-2029) & (K Units)
Table 103. Asia Pacific Dry Powder Inhaler Device Revenue by Country (2018-2023) & (US$ Million)
Table 104. Asia Pacific Dry Powder Inhaler Device Revenue by Country (2024-2029) & (US$ Million)
Table 105. Latin America Dry Powder Inhaler Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Latin America Dry Powder Inhaler Device Sales by Country (2018-2023) & (K Units)
Table 107. Latin America Dry Powder Inhaler Device Sales by Country (2024-2029) & (K Units)
Table 108. Latin America Dry Powder Inhaler Device Revenue by Country (2018-2023) & (US$ Million)
Table 109. Latin America Dry Powder Inhaler Device Revenue by Country (2024-2029) & (US$ Million)
Table 110. Middle East and Africa Dry Powder Inhaler Device Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 111. Middle East and Africa Dry Powder Inhaler Device Sales by Country (2018-2023) & (K Units)
Table 112. Middle East and Africa Dry Powder Inhaler Device Sales by Country (2024-2029) & (K Units)
Table 113. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2018-2023) & (US$ Million)
Table 114. Middle East and Africa Dry Powder Inhaler Device Revenue by Country (2024-2029) & (US$ Million)
Table 115. Global Dry Powder Inhaler Device Sales by Type (2018-2023) & (K Units)
Table 116. Global Dry Powder Inhaler Device Sales by Type (2024-2029) & (K Units)
Table 117. Global Dry Powder Inhaler Device Sales Market Share by Type (2018-2023)
Table 118. Global Dry Powder Inhaler Device Sales Market Share by Type (2024-2029)
Table 119. Global Dry Powder Inhaler Device Revenue by Type (2018-2023) & (US$ Million)
Table 120. Global Dry Powder Inhaler Device Revenue by Type (2024-2029) & (US$ Million)
Table 121. Global Dry Powder Inhaler Device Revenue Market Share by Type (2018-2023)
Table 122. Global Dry Powder Inhaler Device Revenue Market Share by Type (2024-2029)
Table 123. Global Dry Powder Inhaler Device Price by Type (2018-2023) & (USD/Unit)
Table 124. Global Dry Powder Inhaler Device Price by Type (2024-2029) & (USD/Unit)
Table 125. Global Dry Powder Inhaler Device Sales by Application (2018-2023) & (K Units)
Table 126. Global Dry Powder Inhaler Device Sales by Application (2024-2029) & (K Units)
Table 127. Global Dry Powder Inhaler Device Sales Market Share by Application (2018-2023)
Table 128. Global Dry Powder Inhaler Device Sales Market Share by Application (2024-2029)
Table 129. Global Dry Powder Inhaler Device Revenue by Application (2018-2023) & (US$ Million)
Table 130. Global Dry Powder Inhaler Device Revenue by Application (2024-2029) & (US$ Million)
Table 131. Global Dry Powder Inhaler Device Revenue Market Share by Application (2018-2023)
Table 132. Global Dry Powder Inhaler Device Revenue Market Share by Application (2024-2029)
Table 133. Global Dry Powder Inhaler Device Price by Application (2018-2023) & (USD/Unit)
Table 134. Global Dry Powder Inhaler Device Price by Application (2024-2029) & (USD/Unit)
Table 135. Key Raw Materials
Table 136. Raw Materials Key Suppliers
Table 137. Dry Powder Inhaler Device Distributors List
Table 138. Dry Powder Inhaler Device Customers List
Table 139. Dry Powder Inhaler Device Industry Trends
Table 140. Dry Powder Inhaler Device Industry Drivers
Table 141. Dry Powder Inhaler Device Industry Restraints
Table 142. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Dry Powder Inhaler DeviceProduct Picture
Figure 5. Global Dry Powder Inhaler Device Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Dry Powder Inhaler Device Market Size (2018-2029) & (US$ Million)
Figure 7. Global Dry Powder Inhaler Device Sales (2018-2029) & (K Units)
Figure 8. Global Dry Powder Inhaler Device Average Price (USD/Unit) & (2018-2029)
Figure 9. Single Dose Product Picture
Figure 10. Multi Dose Product Picture
Figure 11. Asthma Product Picture
Figure 12. COPD Product Picture
Figure 13. Others Product Picture
Figure 14. Global Dry Powder Inhaler Device Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Dry Powder Inhaler Device, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Dry Powder Inhaler Device, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Dry Powder Inhaler Device Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Dry Powder Inhaler Device Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Dry Powder Inhaler Device Sales by Region in 2022
Figure 21. Global Dry Powder Inhaler Device Revenue by Region in 2022
Figure 22. North America Dry Powder Inhaler Device Market Size by Country in 2022
Figure 23. North America Dry Powder Inhaler Device Sales Market Share by Country (2018-2029)
Figure 24. North America Dry Powder Inhaler Device Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Dry Powder Inhaler Device Market Size by Country in 2022
Figure 28. Europe Dry Powder Inhaler Device Sales Market Share by Country (2018-2029)
Figure 29. Europe Dry Powder Inhaler Device Revenue Market Share by Country (2018-2029)
Figure 30. Germany Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Dry Powder Inhaler Device Market Size by Country in 2022
Figure 36. Asia Pacific Dry Powder Inhaler Device Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Dry Powder Inhaler Device Revenue Market Share by Country (2018-2029)
Figure 38. China Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Dry Powder Inhaler Device Market Size by Country in 2022
Figure 48. Latin America Dry Powder Inhaler Device Sales Market Share by Country (2018-2029)
Figure 49. Latin America Dry Powder Inhaler Device Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Dry Powder Inhaler Device Market Size by Country in 2022
Figure 54. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Dry Powder Inhaler Device Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Dry Powder Inhaler Device Sales Market Share by Type (2018-2029)
Figure 60. Global Dry Powder Inhaler Device Revenue Market Share by Type (2018-2029)
Figure 61. Global Dry Powder Inhaler Device Price (USD/Unit) by Type (2018-2029)
Figure 62. Global Dry Powder Inhaler Device Sales Market Share by Application (2018-2029)
Figure 63. Global Dry Powder Inhaler Device Revenue Market Share by Application (2018-2029)
Figure 64. Global Dry Powder Inhaler Device Price (USD/Unit) by Application (2018-2029)
Figure 65. Dry Powder Inhaler Device Value Chain
Figure 66. Dry Powder Inhaler Device Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Dry Powder Inhaler Device Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Dry Powder Inhaler DeviceProduct Picture
Figure 5. Global Dry Powder Inhaler Device Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Dry Powder Inhaler Device Market Size (2018-2029) & (US$ Million)
Figure 7. Global Dry Powder Inhaler Device Sales (2018-2029) & (K Units)
Figure 8. Global Dry Powder Inhaler Device Average Price (USD/Unit) & (2018-2029)
Figure 9. Single Dose Product Picture
Figure 10. Multi Dose Product Picture
Figure 11. Asthma Product Picture
Figure 12. COPD Product Picture
Figure 13. Others Product Picture
Figure 14. Global Dry Powder Inhaler Device Revenue Share by Manufacturers in 2022
Figure 15. Global Manufacturers of Dry Powder Inhaler Device, Manufacturing Sites & Headquarters
Figure 16. Global Manufacturers of Dry Powder Inhaler Device, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Dry Powder Inhaler Device Players Market Share by Revenue in 2022
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 19. Global Dry Powder Inhaler Device Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. Global Dry Powder Inhaler Device Sales by Region in 2022
Figure 21. Global Dry Powder Inhaler Device Revenue by Region in 2022
Figure 22. North America Dry Powder Inhaler Device Market Size by Country in 2022
Figure 23. North America Dry Powder Inhaler Device Sales Market Share by Country (2018-2029)
Figure 24. North America Dry Powder Inhaler Device Revenue Market Share by Country (2018-2029)
Figure 25. U.S. Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe Dry Powder Inhaler Device Market Size by Country in 2022
Figure 28. Europe Dry Powder Inhaler Device Sales Market Share by Country (2018-2029)
Figure 29. Europe Dry Powder Inhaler Device Revenue Market Share by Country (2018-2029)
Figure 30. Germany Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Dry Powder Inhaler Device Market Size by Country in 2022
Figure 36. Asia Pacific Dry Powder Inhaler Device Sales Market Share by Country (2018-2029)
Figure 37. Asia Pacific Dry Powder Inhaler Device Revenue Market Share by Country (2018-2029)
Figure 38. China Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Dry Powder Inhaler Device Market Size by Country in 2022
Figure 48. Latin America Dry Powder Inhaler Device Sales Market Share by Country (2018-2029)
Figure 49. Latin America Dry Powder Inhaler Device Revenue Market Share by Country (2018-2029)
Figure 50. Mexico Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Argentina Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Middle East and Africa Dry Powder Inhaler Device Market Size by Country in 2022
Figure 54. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Country (2018-2029)
Figure 55. Middle East and Africa Dry Powder Inhaler Device Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Dry Powder Inhaler Device Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Dry Powder Inhaler Device Sales Market Share by Type (2018-2029)
Figure 60. Global Dry Powder Inhaler Device Revenue Market Share by Type (2018-2029)
Figure 61. Global Dry Powder Inhaler Device Price (USD/Unit) by Type (2018-2029)
Figure 62. Global Dry Powder Inhaler Device Sales Market Share by Application (2018-2029)
Figure 63. Global Dry Powder Inhaler Device Revenue Market Share by Application (2018-2029)
Figure 64. Global Dry Powder Inhaler Device Price (USD/Unit) by Application (2018-2029)
Figure 65. Dry Powder Inhaler Device Value Chain
Figure 66. Dry Powder Inhaler Device Production Mode & Process
Figure 67. Direct Comparison with Distribution Share
Figure 68. Distributors Profiles
Figure 69. Dry Powder Inhaler Device Industry Opportunities and Challenges
